CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $729,889 | +41.2% | 48,953 | +3.7% | 0.01% | +66.7% |
| Q2 2023 | $516,982 | +294.6% | 47,213 | +11.7% | 0.00% | +200.0% |
| Q1 2022 | $131,000 | +5.6% | 42,257 | +14.7% | 0.00% | 0.0% |
| Q4 2021 | $124,000 | -10.1% | 36,834 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $138,000 | -18.3% | 37,936 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $169,000 | -7.7% | 38,837 | -3.8% | 0.00% | 0.0% |
| Q1 2021 | $183,000 | -20.8% | 40,372 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $231,000 | -23.0% | 40,265 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $300,000 | +102.7% | 41,420 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $148,000 | +146.7% | 42,362 | +3.9% | 0.00% | – |
| Q1 2020 | $60,000 | -29.4% | 40,777 | -5.5% | 0.00% | – |
| Q4 2019 | $85,000 | -61.9% | 43,133 | -0.8% | 0.00% | -100.0% |
| Q3 2019 | $223,000 | -29.0% | 43,497 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $314,000 | -37.8% | 43,799 | +15.2% | 0.00% | -50.0% |
| Q1 2019 | $505,000 | +65.6% | 38,005 | -2.0% | 0.00% | +100.0% |
| Q4 2018 | $305,000 | -29.6% | 38,794 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $433,000 | -15.9% | 39,093 | +1.8% | 0.00% | -50.0% |
| Q2 2018 | $515,000 | – | 38,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |